Funding search · EIN 263241764 · Houston, TX

Laura and John Arnold Foundation

Name: Laura and John Arnold Foundation grants, 2020–2024
Creator: PaperOrbit
License: https://www.irs.gov/charities-non-profits/exempt-organization-public-disclosure-and-availability-requirements

A private foundation (files IRS Form 990-PF). Most private foundations do not take unsolicited applications; the route in is usually a program officer.

2,588
grants reported: $754.5M
total given: 2020–2024
filing years: $138,933
median grant

Based on grants this organization reported to the IRS for tax years 2020–2024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

research policy randomized trial controlled state conduct care

Funder website ↗Full IRS filings ↗How this is built Report an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Where the money goes

Criminal justice research: pretrial, policing, sentencing, community supervision
Health care cost and drug pricing policy analysis for policymakers
Randomized controlled trials and evidence-to-policy infrastructure (J-PAL, MDRC)
Medicare Advantage, dual-eligibles, and insurance market research
K-12 and postsecondary education reform, student lending accountability
Housing supply, zoning reform, fiscal and tax policy analysis

Typical grant

Median grant is $138,933, with the middle half between $50,713 and $297,174. University research projects and evaluations cluster in the $500,000 to $1,000,000 range; the eight-figure checks go to long-term intermediary partners like The City Fund and MDRC receiving general operating support. Repeat funding is heavy, with MIT, RAND, Yale, Penn, Brown, Harvard, Kaiser Family Foundation, and Urban Institute appearing multiple times across years.

Their words

Phrases from their own grant descriptions, worth speaking back to them.

“randomized controlled trial”
“to inform policy discussions”
“evidence-based”
“technical assistance to policymakers”
“policy translation”
“nonpartisan”

Positioning adjacent work

Lead with a causal design: RCT or rigorous evaluation, not descriptive work or program delivery.
Name the specific policymaker audience and the decision your findings will inform.
Ask $500K to $1M for a single university research project; larger only with institutional track record.
Connect to a live reform: pretrial assessment, Medicare Advantage payment, zoning, drug pricing, or supervision revocations.
Pair research with a dissemination or technical assistance arm; they fund translation, not just findings.

Worth knowing: Money concentrates in DC think tanks and a small set of elite research universities, and the same institutions recur year after year, so this reads as a relationship-driven portfolio built around known research teams. Recent years show heavy weighting toward health care cost containment and criminal justice evaluation, with education flowing mostly through a few large intermediaries rather than individual scholars.

129 grants matching “drugs” · $42.0M

$2.0M
Johns Hopkins University · Baltimore, MD · 2024
To continue to develop and publicly disseminate policy options to regulate and control drug spending.
$1.5M
The Brigham and Women'S Hospital · Boston, MA · 2024
To support the program on regulation, therapeutics, and law ("portal") project on prescription drug policy and promoting meaningful drug innovation and regulation.
$1.0M
Henry J Kaiser Family Foundation · San Francisco, CA · 2024
To support new research and data analysis to inform forthcoming policy discussions related to medicare sustainability and affordability in four areas: 1) medicare advantage; 2) medicare spending, financing, and affordab… read allTo support new research and data analysis to inform forthcoming policy discussions related to medicare sustainability and affordability in four areas: 1) medicare advantage; 2) medicare spending, financing, and affordability; 3) medicare and prescription drugs in the post-inflation reduction act era; and 4) rapid-response analyses of emerging medicare policy issues. less
$812,502
Oregon Health & Science University · Portland, OR · 2024
To provide technical assistance for states implementing pharmaceutical policy interventions that lower drug prices.
$665,000
Brookings Institution · Washington, DC · 2024
To analyze a series of developments in prescription drug markets with the goal of understanding the consequences of various responses policy makers might adopt to the resulting market dynamics.
$551,403
Emory University · Atlanta, GA · 2024
To explore the pros and cons of computational simulation in clinical trials, using ai/ml methods to produce simulated controls at either the aggregate or the individual level, to measure the safety and effectiveness of … read allTo explore the pros and cons of computational simulation in clinical trials, using ai/ml methods to produce simulated controls at either the aggregate or the individual level, to measure the safety and effectiveness of a drug and develop policy recommendations. less
$500,000
Reboot Rx · Winchester, MA · 2024
To (1) research and explore policies that would enable the fda to incorporate updated information on a repurposed generic drug's label and (2) create payer-directed materials that communicate the impact and value of a r… read allTo (1) research and explore policies that would enable the fda to incorporate updated information on a repurposed generic drug's label and (2) create payer-directed materials that communicate the impact and value of a repurposed generic drug. less
$419,494
President and Fellows of Harvard College · Cambridge, MA · 2024
To (i) provide comprehensive analysis of regulatory flexibilities that use lower evidence standards for fda approval; and (ii) develop new labeling strategies to describe the limitations and uncertainties of clinical be… read allTo (i) provide comprehensive analysis of regulatory flexibilities that use lower evidence standards for fda approval; and (ii) develop new labeling strategies to describe the limitations and uncertainties of clinical benefit for new drugs. less
$350,000
Georgetown University · Washington, DC · 2024
To provide legal expertise regarding the medicare drug price negotiation program outlined in the inflation reduction act, and to defend and support the implementation of federal and state efforts addressing the affordab… read allTo provide legal expertise regarding the medicare drug price negotiation program outlined in the inflation reduction act, and to defend and support the implementation of federal and state efforts addressing the affordability and accessibility of prescription drugs. less
$348,550
National Opinion Research Center · Chicago, IL · 2024
To (i) develop a comprehensive overview of the present landscape of social media advertising trends, regulatory activity, and key stakeholders' reactions to prescription drug marketing by social media influencers; (ii) … read allTo (i) develop a comprehensive overview of the present landscape of social media advertising trends, regulatory activity, and key stakeholders' reactions to prescription drug marketing by social media influencers; (ii) acquire a comprehensive understanding of prescribers? And consumers' experiences with direct-to-consumer social media drug marketing and the extent to which this marketing affects prescribing requests; and (iii) publicly disseminating policy and regulatory solutions related to same. less
$283,005
Duke University · Durham, NC · 2024
To conduct analyses and provide evidence-based policy recommendations that can support review, approval, and promotion of new indications for safe, effective, affordable generic drugs.
$260,000
Initiative for Medicines Access & Knowledge · Lewes, DE · 2024
To support the purpose of developing and advancing a comprehensive set of policy options for intellectual property reform in the drug space through research, public education, and policy development.
$250,000
University of Chicago · Chicago, IL · 2024
To conduct research to identify oncology drugs that are not dose-optimized and assess their potential savings in connection with making the case for the fda requirement of post-marketing dose optimization trials.
$221,240
Reboot Rx · Winchester, MA · 2024
To research stakeholders that influence whether repurposed generic drugs are ultimately prescribed for cancer patients, and to develop a strategy for driving adoption of new repurposed generic drugs into the standard of… read allTo research stakeholders that influence whether repurposed generic drugs are ultimately prescribed for cancer patients, and to develop a strategy for driving adoption of new repurposed generic drugs into the standard of care. less
$200,773
Trustees of the University of Pennsylvania · Philadelphia, PA · 2024
To inform policy that balances speed and certainty in fda drug approvals.
$165,000
National Conference of State Legislatures · Denver, CO · 2024
To support grantee's efforts to provide nonpartisan and evidence-based resources in connection with the development of prescription drug policy efforts at the state level.
$149,224
Institute for Community Health · Malden, MA · 2024
To document the national landscape of drug testing policy in probation and parole agencies.
$145,167
Brookings Institution · Washington, DC · 2024
To support policies for the effective regulation and functioning of prescription drug markets.
$125,000
Trustees of the University of Pennsylvania · Philadelphia, PA · 2024
To develop a novel scoring system to systematically identify promising drug repurposing opportunities that maximize impact on patients and economic impact on the health care system.
$99,200
President and Fellows of Harvard College · Cambridge, MA · 2024
To assess how list prices affect out-of-pocket costs, formulary coverage, and negotiated prices in prescription drug markets.
$88,126
Drug Policy Alliance · New York, NY · 2024
To provide information to inform the federal policy debate on removing snap benefits for people with criminal records.
$52,557
Regents of the University of Colorado · Denver, CO · 2024
To conduct research by using medicare advantage encounter data and traditional medicare claims to develop a process to include medicare advantage data in the calculation of inflation rebates for part b drugs, with the u… read allTo conduct research by using medicare advantage encounter data and traditional medicare claims to develop a process to include medicare advantage data in the calculation of inflation rebates for part b drugs, with the ultimate goal of providing technical guidance to centers for medicare & medicaid services to improve the implementation of rebate calculations under the inflation reduction act for part b drugs. less
$43,333
Bipartisan Policy Center · Washington, DC · 2024
To support the assessment of policy changes that widen the gap between the food and drug administration and centers for medicare and medicaid services to enhance interagency communication.
$39,267
Justice Innovation · New York, NY · 2024
To examine the use, overuse, and misuse of mandatory drug testing in probation and parole systems; develop an approach to drug use consistent with advances in addiction science; and spur reforms consistent with that res… read allTo examine the use, overuse, and misuse of mandatory drug testing in probation and parole systems; develop an approach to drug use consistent with advances in addiction science; and spur reforms consistent with that research. less
$29,861
Georgetown University · Washington, DC · 2024
To provide technical assistance and policy expertise regarding the medicare drug price negotiation program outlined in the inflation reduction act.
$20,143
The Regents of the University of California Davis · Davis, CA · 2024
To improve the quality of drugs approved by the food and drug administration by documenting areas of improvement for clinical trial regulations.
$16,372
Rand Corporation · Santa Monica, CA · 2024
To support research analyzing u.s. Drug pricing compared to pricing in other countries for certain drugs.
$15,160
Rand Corporation · Santa Monica, CA · 2024
To analyze literature and develop a new approach to estimating research and development costs on drug innovation and prices.
$9,513
Prep4all · Brooklyn, NY · 2024
To analyze potential costs of a national program aimed at increasing access to low-cost generic drugs for uninsured and underinsured individuals.
$8,000
Reagan-Udall Foundation for the Food and Drug Administration · Washington, DC · 2024
To develop a roadmap for the food and drug administration ("fda") to make data more easily accessible to patients, caregivers, health care professionals, and researchers to facilitate integration of fda's data into digi… read allTo develop a roadmap for the food and drug administration ("fda") to make data more easily accessible to patients, caregivers, health care professionals, and researchers to facilitate integration of fda's data into digital applications. less
$5,000
Food and Drug Law Institute · Washington, DC · 2024
To support the food and drug law institutes annual conference, which brings together experts from government, industry, non-profit organizations, patient and consumer groups, and academics to discuss the complex legal, … read allTo support the food and drug law institutes annual conference, which brings together experts from government, industry, non-profit organizations, patient and consumer groups, and academics to discuss the complex legal, regulatory, compliance, and policy issues currently impacting the fda-regulated industry. less
$1.5M
The Brigham and Womens Hospital · Boston, MA · 2023
To support the program on regulation, therapeutics, and law ("portal") project on prescription drug policy and promoting meaningful drug innovation and regulation.
$650,000
The Regents of the University of California San Francisco · San Francisco, CA · 2023
To evaluate newly approved cancer drugs while developing policy related to the approval and coverage of novel molecular tests and screening technologies.
$520,000
Initiative for Medicines Access & Knowledge · Lewes, DE · 2023
To support the purpose of developing and advancing a comprehensive set of policy options for intellectual property reform in the drug space through research, public education, and policy development.
$510,000
Trustees of the University of Pennsylvania · Philadelphia, PA · 2023
To develop a novel scoring system to systematically identify promising drug repurposing opportunities that maximize impact on patients and economic impact on the health care system.
$420,000
Vanderbilt University Medical Center · Nashville, TN · 2023
To evaluate the inflation reduction act's impact on changes in drug pricing, insurer benefit design, and use of anticancer drugs among medicare beneficiaries.
$356,667
Bipartisan Policy Center · Washington, DC · 2023
To support the assessment of policy changes that widen the gap between the food and drug administration and centers for medicare and medicaid services to enhance interagency communication.
$330,198
Brookings Institution · Washington, DC · 2023
To support policies for the effective regulation and functioning of prescription drug markets.
$325,000
University of Washington · Chicago, IL · 2023
To evaluate washington state's "netflix" model for purchasing hepatitis c drugs.
$311,224
Justice System Partners · South Easton, MA · 2023
To measure the effect of removing drug testing as a supervision requirement for people without a serious substance use issue on community supervision outcomes and recidivism.
$278,800
Reboot Rx · Winchester, MA · 2023
To research stakeholders that influence whether repurposed generic drugs are ultimately prescribed for cancer patients, and to develop a strategy for driving adoption of new repurposed generic drugs into the standard of… read allTo research stakeholders that influence whether repurposed generic drugs are ultimately prescribed for cancer patients, and to develop a strategy for driving adoption of new repurposed generic drugs into the standard of care. less
$265,000
Trustees of the University of Pennsylvania · Philadelphia, PA · 2023
To construct the largest "living" database involving oncology drugs granted fda accelerated approval.
$265,000
Project Ds · Morrisville, NC · 2023
To define immune-related adverse events for fda review of drug safety to promote fda accountability for standardizing case report forms.
$260,000
Georgetown University · Washington, DC · 2023
To provide technical assistance and policy expertise regarding the medicare drug price negotiation program outlined in the inflation reduction act.
$209,391
The Brigham and Womens Hospital · Boston, MA · 2023
To evaluate factors that influence how doctors make antimicrobial drug prescribing decisions.
$200,000
Justice Innovation · New York, NY · 2023
To examine the use, overuse, and misuse of mandatory drug testing in probation and parole systems.
$189,000
Reagan-Udall Foundation for the Food and Drug Administration · Washington, DC · 2023
To develop a roadmap for the food and drug administration ("fda") to make data more easily accessible to patients, caregivers, health care professionals, and researchers to facilitate integration of fda's data into digi… read allTo develop a roadmap for the food and drug administration ("fda") to make data more easily accessible to patients, caregivers, health care professionals, and researchers to facilitate integration of fda's data into digital applications. less
$161,447
Regents of the University of California at Berkeley · Berkeley, CA · 2023
To estimate the effect of a policy change expanding eligibility for supplemental nutrition assistance program ("snap") and temporary assistance for needy families ("tanf") to people with felony drug convictions on their… read allTo estimate the effect of a policy change expanding eligibility for supplemental nutrition assistance program ("snap") and temporary assistance for needy families ("tanf") to people with felony drug convictions on their likelihood of returning to prison. less
$150,000
Institute for Community Health · Malden, MA · 2023
To document the national landscape of drug testing policy in probation and parole agencies.
$140,000
Trustees of Boston University · Boston, MA · 2023
To support research in order to better understand the impact of government investment in small biotech companies and later stage drug development on the prescription drug market in the united states.
$137,960
Memorial Sloan-Kettering Cancer Center · New York, NY · 2023
To evaluate "perverse incentives" of high prescription drug prices adversely affect cancer care quality and costs to beneficiaries and the medicare program.
$130,000
University of Chicago · Chicago, IL · 2023
To conduct research to identify oncology drugs that are not dose-optimized and assess their potential savings in connection with making the case for the fda requirement of post-marketing dose optimization trials.
$110,000
Prep4all · Brooklyn, NY · 2023
To analyze potential costs of a national program aimed at increasing access to low-cost generic drugs for uninsured and underinsured individuals.
$99,114
President and Fellows of Harvard College · Cambridge, MA · 2023
To assess how list prices affect out-of-pocket costs, formulary coverage, and negotiated prices in prescription drug markets.
$94,487
New York University · New York, NY · 2023
To research the impacts of the 340b drug pricing program on physician-administered drug prices and drug administration for a large population of privately insured patients.
$89,355
Regents of the University of California at Berkeley · Berkeley, CA · 2023
To study economics of pharmacy benefit managers within the drugs supply chain.
$57,926
Urban Institute · Washington, DC · 2023
To develop a methodology to more accurately estimate drug rebates and discounts for use by researchers.
$50,056
Johns Hopkins University · Baltimore, MD · 2023
To develop and disseminate research on policy options that maximize access to and affordability of prescription drugs without stifling innovation.
$37,153
Tufts Medical Center · Boston, MA · 2023
To assess how the fda and cms can coordinate drug approval and medicare coverage determinations for new drugs and biologic approved under accelerated approval paths with lower clinical evidence standards.
$36,386
Washington University · Saint Louis, MO · 2023
To research medicaid spending on prescription drugs under the food and drug administration's accelerated approval pathway with unclear clinical benefits.
$33,794
3 Axis Advisors Llc · Bellbrook, OH · 2023
To help policymakers better understand the economics behind the medicaid prescription drug program.
$25,000
National Conference of State Legislatures · Denver, CO · 2023
To support nonpartisan educational resource for policymakers and key stakeholders on policy ideas to address prescription drug pricing and other similar issues.
$21,648
R Street Institute · Washington, DC · 2023
To support research with respect to pharmaceutical drug policies.
$9,955
Health Management Associates · Lansing, MI · 2023
To examine the 340b drug discount program's impact on drug pricing.
$7,998
Continuum Health Group Llc · Washington, DC · 2023
To improve drug and biologic evidentiary standards and clinical trial data transparency at the u.s. Food and drug administration.
$5,000
Trustees of the University of Pennsylvania · Philadelphia, PA · 2023
To support a conference, a prescription for the future of drug pricing.
$832,397
Oregon Health & Science University · Portland, OR · 2022
To provide technical assistance for states implementing pharmaceutical policy interventions that lower drug prices.
$674,982
Continuum Health Group Llc · Washington, DC · 2022
To improve drug and biologic evidentiary standards and clinical trial data transparency at the u.s. Food and drug administration.
$608,635
Brookings Institution · Washington, DC · 2022
To support policies for the effective regulation and functioning of prescription drug markets.
$520,000
Initiative for Medicines Access & Knowledge · Lewes, DE · 2022
To support the purpose of developing and advancing a comprehensive set of policy options for intellectual property reform in the drug space through research, public education, and policy development.
$325,000
University of Washington · Seattle, WA · 2022
To evaluate washington state's "netflix" model for purchasing hepatitis c drugs.
$235,764
Tufts Medical Center · Boston, MA · 2022
To assess how the fda and cms can coordinate drug approval and medicare coverage determinations for new drugs and biologic approved under accelerated approval paths with lower clinical evidence standards.
$226,570
Memorial Sloan-Kettering Cancer Center · New York, NY · 2022
To support grantee's continued efforts to communicates viable, evidence-based methodologies and solutions to drug pricing that balance patient affordability with sustained incentives for innovation.
$209,855
The Brigham and Women'S Hospital · Boston, MA · 2022
To evaluate factors that influence how doctors make antimicrobial drug prescribing decisions.
$207,736
Trustees of the University of Pennsylvania · Philadelphia, PA · 2022
To inform policy that balances speed and certainty in fda drug approvals.
$200,000
R Street Institute · Washington, DC · 2022
To support research with respect to pharmaceutical drug policies.
$184,818
Rand Corporation · Santa Monica, CA · 2022
To support estimating the return on investment in drug research and development.
$145,000
National Conference of State Legislatures · Denver, CO · 2022
To support nonpartisan educational resource for policymakers and key stakeholders on policy ideas to address prescription drug pricing and other similar issues.
$140,000
Trustees of Boston University · Boston, MA · 2022
To support research in order to better understand the impact of government investment in small biotech companies and later stage drug development on the prescription drug market in the united states.
$134,788
New York University · New York, NY · 2022
To research the impacts of the 340b drug pricing program on physician-administered drug prices and drug administration for a large population of privately insured patients.
$112,580
Rand Corporation · Santa Monica, CA · 2022
To support research analyzing u.s. Drug pricing compared to pricing in other countries for certain drugs.
$110,000
The Regents of the University of California Davis · Davis, CA · 2022
To improve the quality of drugs approved by the food and drug administration by documenting areas of improvement for clinical trial regulations.
$102,517
Regents of the University of California at Berkeley · Berkeley, CA · 2022
To study economics of pharmacy benefit managers within the drugs supply chain.
$89,595
Health Management Associates · Lansing, MI · 2022
To examine the 340b drug discount program's impact on drug pricing.
$86,733
Yale University · New Haven, CT · 2022
To research biologic prices, spending, and utilization of physician-administered drugs in the commercial market.
$82,210
Cornell University · Ithaca, NY · 2022
To evaluate the intended and unintended consequences of proliferating state policies to limit unnecessary opioid prescribing, particularly policies designed to increase provider use of prescription drug monitoring progr… read allTo evaluate the intended and unintended consequences of proliferating state policies to limit unnecessary opioid prescribing, particularly policies designed to increase provider use of prescription drug monitoring programs. less
$72,311
Waxman Consulting · Washington, DC · 2022
To provide nonpartisan information and technical assistance to stakeholders to help lower prescription drug prices and commercial sector prices.
$50,000
National Academy of Sciences · Washington, DC · 2022
To host a workshop on the u.s. Food and drug administration's use of the accelerated approval program for new pharmaceuticals.
$47,500
United States Public Interest Research Group Education Fund · Denver, CO · 2022
To develop educational materials to highlight common patent abuse tactics used to keep lower costs generics and biosimilar products out of the marketplace and improve consumer and stakeholder understanding of drug prici… read allTo develop educational materials to highlight common patent abuse tactics used to keep lower costs generics and biosimilar products out of the marketplace and improve consumer and stakeholder understanding of drug pricing issues ripe for reform. less
$36,438
Johns Hopkins University · Baltimore, MD · 2022
To promote the adoption of a waste-free prescription drug formulary by private corporations in place of the current drug rebate system.
$36,182
Regents of the University of California at Berkeley · Berkeley, CA · 2022
To research competition and mergers in the pharmacy benefit manager industry to lay the groundwork for policies that drive down drug spending.
$35,385
Washington University · Saint Louis, MO · 2022
To provide stakeholders with transparent information about food and drug administration approved and experimental medications.
$21,083
Medicines360 · San Francisco, CA · 2022
To examine how prescription drugs can be developed by a nonprofit company.
$14,453
Trustees of Boston University · Boston, MA · 2022
To analyze the relationship between prices, regulations, and investments in prescription drugs.
$7,046
Rand Corporation · Santa Monica, CA · 2022
To compare net prices for u.s. Prescription drugs against other high-income countries.
$4,122
Oregon Health & Science University · Portland, OR · 2022
To fund the state medicaid alternative reimbursement and purchasing test for high cost drugs (smart-d) and support the development of value-based alternative drug purchasing models through pharmacy policy interventions,… read allTo fund the state medicaid alternative reimbursement and purchasing test for high cost drugs (smart-d) and support the development of value-based alternative drug purchasing models through pharmacy policy interventions, technical assistance, and education less
$1,702
Georgetown University · Washington, DC · 2022
To convene a workshop of academics, experts and key stakeholders to discuss ways to improve the food and drug administration product approval process.
$6.4M
Evidence for Healthcare Improvement · Boston, MA · 2020
To support the institute for clinical and economic review research that provides independent analyses of the comparative cost effectiveness for newly-introduced pharmaceutical drugs.
$1.8M
Center for Health Policy Development · Portland, ME · 2020
To provide educational resources for prescription drug and commercial health care prices.
$1.8M
Memorial Sloan-Kettering Cancer Center · New York, NY · 2020
To support grantee's continued efforts to communicates viable, evidence-based methodologies and solutions to drug pricing that balance patient affordability with sustained incentives for innovation.
$1.6M
Oregon Health & Science University · Portland, OR · 2020
To fund the state medicaid alternative reimbursement and purchasing test for high cost drugs (smart-d) and support the development of value-based alternative drug purchasing models through pharmacy policy interventions,… read allTo fund the state medicaid alternative reimbursement and purchasing test for high cost drugs (smart-d) and support the development of value-based alternative drug purchasing models through pharmacy policy interventions, technical assistance, and education. less
$1.5M
Johns Hopkins University · Baltimore, MD · 2020
To develop and disseminate research on policy options that maximize access to and affordability of prescription drugs without stifling innovation.
$600,000
Hastings College of the Law University of California · San Francisco, CA · 2020
To support grantee's center for innovation in its efforts to maximize the access and affordability of life saving drugs while maintaining incentives for innovation.
$550,000
Uc Hastings Foundation · San Francisco, CA · 2020
To support grantee's center for innovation in its efforts to maximize the access and affordability of life saving drugs while maintaining incentives for innovation.
$295,000
Patients for Affordable Drugs · Washington, DC · 2020
To provide operating support for the patient-centered coalition initiative.
$250,000
Doctors for America · Washington, DC · 2020
To develop a physician-centered coalition that will educate the public and key stakeholders about prescription drug pricing in the united states.
$250,000
3 Axis Advisors Llc · Bellbrook, OH · 2020
To help policymakers better understand the economics behind the medicaid prescription drug program.
$250,000
Rand Corporation · Santa Monica, CA · 2020
To analyze literature and develop a new approach to estimating research and development costs on drug innovation and prices.
$249,528
Urban Institute · Washington, DC · 2020
To analyze state-level data on prescription drugs used to treat opioid use disorder and opioid overdoses.
$230,000
Urban Institute · Washington, DC · 2020
To develop a methodology to more accurately estimate drug rebates and discounts for use by researchers.
$220,000
Regents of the University of California at Berkeley · Berkeley, CA · 2020
To research competition and mergers in the pharmacy benefit manager industry to lay the groundwork for policies that drive down drug spending.
$200,000
Brigham and Women'S Hospital · Boston, MA · 2020
To support the promoting a competitive market for high-cost biologic drugs project.
$200,000
Cornell University · Ithaca, NY · 2020
To evaluate the intended and unintended consequences of proliferating state policies to limit unnecessary opioid prescribing, particularly policies designed to increase provider use of prescription drug monitoring progr… read allTo evaluate the intended and unintended consequences of proliferating state policies to limit unnecessary opioid prescribing, particularly policies designed to increase provider use of prescription drug monitoring programs, with the overall goal of creating an evidence base to inform state action on opioid prescribing policies. less
$195,720
Johns Hopkins University · Baltimore, MD · 2020
To promote the adoption of a waste-free prescription drug formulary by private corporations in place of the current drug rebate system.
$175,000
Washington University · Saint Louis, MO · 2020
To research medicaid spending on prescription drugs under fda's accelerated approval pathway with unclear clinical benefits.
$150,000
Drug Policy Alliance · New York, NY · 2020
To support work focused on the intersection of harm reduction and substance use disorder treatment.
$130,000
Rand Corporation · Santa Monica, CA · 2020
To compare net prices for u.s. Prescription drugs against other high-income countries.
$120,000
National Conference of State Legislatures · Denver, CO · 2020
To educate policymakers and stakeholders on drug pricing and surprise billing policies.
$119,336
Henry J Kaiser Family Foundation · San Francisco, CA · 2020
To examine trends in prescription drug prices and medicare part d formulary coverage and broadly disseminate the findings policy briefs, papers, and convenings.
$117,877
T1international USA · Indianapolis, IN · 2020
To support efforts to educate people about rising prescription drug prices.
$112,006
Regents of the University of California at Berkeley · Berkeley, CA · 2020
To study the impact of extending reference pricing incentives to high-cost specialty pharmaceutical classes and physician-administered drugs.
$110,000
Henry J Kaiser Family Foundation · San Francisco, CA · 2020
To provide researchers, policymakers, and the public with accessible, unbiased information about the medicaid pharmacy benefit and policy options to lower medicaid drug spending.
$106,653
Center for Health Policy Development · Portland, ME · 2020
To support the launch of the center for prescription drug price action.
$90,000
Healthpartners Institute · Minneapolis, MN · 2020
To analyze the characteristics and consequences of off patent, non-competitive drugs, and assist policymakers in developing policy proposals to address price spikes common among these types of drugs.
$80,000
Medicines360 · San Francisco, CA · 2020
To examine how prescription drugs can be developed by a nonprofit company.
$74,648
Health Care for All · Boston, MA · 2020
To educate the public, policymakers, and key stakeholders about drug price increases and increased drug pricing transparency, and strengthen efforts to counter marketing efforts by the pharmaceutical industry.
$64,559
National Academy of Sciences · Washington, DC · 2020
To host a workshop examining the role of the national institutes of health in prescription drug innovation in order increase patient access to products derived in part from federal research.
$40,000
President and Fellows of Harvard College · Cambridge, MA · 2020
To analyze the impact of patient assistance programs on prescription drug pricing in the united states.
$9,497
Waxman Consulting · Washington, DC · 2020
To create an evidence-base to support the policy debate related to high prescription drug pricing.

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

The City Fund3 grants · $30.9M
Massachusetts Institute of Technology19 grants · $28.2M
Urban Institute76 grants · $26.4M
Mdrc40 grants · $24.7M
Trustees of the University of Pennsylvania41 grants · $21.6M
President and Fellows of Harvard College65 grants · $21.1M
Center for Effective Public Policy5 grants · $17.0M
Research Triangle Institute39 grants · $14.5M
Accelerate - the National Collaborative for Accelerated Learning2 grants · $13.3M
Regents of the University of California at Berkeley56 grants · $11.1M

Giving over time

$212.4M

2020

$185.8M

2022

$162.9M

2023

$193.3M

2024

Grant history

The 100 largest of 2,588 grants.

$17.3M
The City Fund · Falls Church, VA · 2020
To provide general operating support.
$12.5M
The City Fund · Beaverton, OR · 2024
To provide general operating support to support grantee's efforts to partner with local leaders to create innovative public school systems, with the overall goal of improving the quality of public education in cities ac… read allTo provide general operating support to support grantee's efforts to partner with local leaders to create innovative public school systems, with the overall goal of improving the quality of public education in cities across the united states. less
$10.0M
Accelerate - the National Collaborative for Accelerated Learning · Nashville, TN · 2023
To support the national tutoring program.
$10.0M
America Achieves · New York, NY · 2022
To support a national tutoring program and accompanying research to improve academics and wellness for students.
$10.0M
Civica Foundation · Lehi, UT · 2022
To support the grantee's program to produce nonprofit biosimilar insulin.
$6.4M
Evidence for Healthcare Improvement · Boston, MA · 2020
To support the institute for clinical and economic review research that provides independent analyses of the comparative cost effectiveness for newly-introduced pharmaceutical drugs.
$5.0M
Urban Institute · Washington, DC · 2020
To support research to advance and elevate tax and spending policy.
$5.0M
Mdrc · New York, NY · 2024
To support grantee to develop and advance multiple strategies to significantly increase its organizational impact in areas including: (i) strengthening connections between its research and policymakers; (ii) building a … read allTo support grantee to develop and advance multiple strategies to significantly increase its organizational impact in areas including: (i) strengthening connections between its research and policymakers; (ii) building a more rigorous approach to technical assistance; (iii) advancing its leadership on the use of new evaluation methodologies and data; and (iv) leveraging data efficiently for evaluation, decision-making, and program improvement. less
$5.0M
Habitat for Humanity International · Americus, GA · 2023
To provide a program-related investment in support of habitat affiliates with early-stage capital for affordable housing development.
$5.0M
Habitat for Humanity International · Americus, GA · 2022
To provide habitat affiliates with early-stage capital for affordable housing development.
$4.8M
Center for Effective Public Policy · Kensington, MD · 2020
To provide training and technical assistance for the public safety assessment and pretrial reform.
$4.6M
Center for Effective Public Policy · Kensington, MD · 2023
To provide training and technical assistance for the public safety assessment and pretrial reform.
$4.0M
Justice Action Network Foundation · Washington, DC · 2023
To support grantee's charitable and non-partisan criminal justice reform activities.
$4.0M
Massachusetts Institute of Technology · Cambridge, MA · 2020
To support the abdul latif jameel poverty action lab's north america regional office.
$3.5M
Massachusetts Institute of Technology · Cambridge, MA · 2024
To support j-pal north america, including by funding landmark randomized evaluations, expanding the capacity and diversity of researchers who work on randomized evaluations, translating findings into actionable insights… read allTo support j-pal north america, including by funding landmark randomized evaluations, expanding the capacity and diversity of researchers who work on randomized evaluations, translating findings into actionable insights that inform policy at scale, and institutionalizing the use of evidence as a driving force behind u.s. Policymaking. less
$3.5M
Massachusetts Institute of Technology · Cambridge, MA · 2023
To support the abdul latif jameel poverty action lab north america in its work to generate randomized controlled trials that measure the impact of social programs and policies.
$3.5M
Massachusetts Institute of Technology · Cambridge, MA · 2022
To support the abdul latif jameel poverty action lab north america in its work to generate randomized controlled trials that measure the impact of social programs and policies.
$3.5M
Center for Effective Public Policy · Kensington, MD · 2022
To provide training and technical assistance for the public safety assessment and pretrial reform.
$3.3M
Accelerate - the National Collaborative for Accelerated Learning · Nashville, TN · 2024
To support grantee's states leading recovery grant program.
$3.2M
Coalition for Public Safety · Washington, DC · 2020
To support nonpartisan criminal justice reform efforts in 2020.
$3.2M
Mdrc · New York, NY · 2020
To study the impacts of preschool, summer curricula, and enhanced teacher training on early childhood learning.
$3.1M
Children'S Hospital Corporation Dba Children'S Hospital Boston · Boston, MA · 2020
To fund a randomized controlled trial analyzing how carbohydrates, fat, and added sugar affect body fat and metabolism.
$3.1M
Persistent Surveillance Systems Llc · Xenia, OH · 2020
To conduct a six-month pilot test of the aerial investigative research program to assist the baltimore city police department.
$3.0M
Center for Effective Public Policy · Kensington, MD · 2024
To provide training and technical assistance for the public safety assessment and pretrial reform.
$3.0M
Coalition for Public Safety · Washington, DC · 2022
To provide general operating support.
$3.0M
Massachusetts Institute of Technology · Cambridge, MA · 2024
To support the abdul latif jameel poverty action lab north america in its work to generate randomized controlled trials that measure the impact of social programs and policies.
$3.0M
Urban Institute · Washington, DC · 2023
To fund the tax policy center.
$3.0M
President and Fellows of Harvard College · Cambridge, MA · 2022
To provide general operating support.
$3.0M
Urban Institute · Washington, DC · 2022
To fund the tax policy center.
$3.0M
President and Fellows of Harvard College · Cambridge, MA · 2020
To provide general operating support.
$2.8M
President and Fellows of Harvard College · Cambridge, MA · 2020
To support the operations of the harvard healthcare markets and regulations lab.
$2.5M
Research Triangle Institute · Research Triangle Park, NC · 2020
To conduct research on the public safety assessment in up to ten research and implementation sites.
$2.5M
Charter Fund · Broomfield, CO · 2020
To support the expansion and replication of high-quality schools in camden, new jersey.
$2.5M
Pew Charitable Trusts · Philadelphia, PA · 2020
To support improved management of state and local public retirement systems.
$2.5M
William Marsh Rice University · Houston, TX · 2020
To provide operational support to launch the texas policy lab.
$2.4M
Urban Institute · Washington, DC · 2022
To launch a prison research and innovation initiative to infuse transparency, accountability, and innovation into the prison sector.
$2.3M
Massachusetts Institute of Technology · Cambridge, MA · 2022
To support the abdul latif jameel poverty action lab's north america regional office.
$2.3M
New Venture Fund · Washington, DC · 2020
To support the clean slate campaign.
$2.2M
Trustees of the University of Pennsylvania · Philadelphia, PA · 2020
To support implementation of the transitional care model across four hospital systems.
$2.1M
Vera Institute of Justice · Brooklyn, NY · 2022
To help reimagine the american prison system through strategic communications and expanding and evaluating the restoring promise initiative.
$2.0M
Johns Hopkins University · Baltimore, MD · 2024
To continue to develop and publicly disseminate policy options to regulate and control drug spending.
$2.0M
Vera Institute of Justice · Brooklyn, NY · 2024
To support the restoring promise initiative that partners with state departments of corrections to design and facilitate rigorous evaluation of reimagined housing units for incarcerated young adults in a way that center… read allTo support the restoring promise initiative that partners with state departments of corrections to design and facilitate rigorous evaluation of reimagined housing units for incarcerated young adults in a way that centers human dignity, safety, and race equity. less
$2.0M
Trustees of the University of Pennsylvania · Philadelphia, PA · 2022
To support improvement of the penn wharton budget model.
$2.0M
Trustees of the University of Pennsylvania · Philadelphia, PA · 2020
To support the analysis and impact of federal budget policy reform proposals for policymakers.
$2.0M
Urban Institute · Washington, DC · 2020
To launch a prison research and innovation initiative to infuse transparency, accountability, and innovation into the prison sector.
$2.0M
Georgetown University · Washington, DC · 2024
To support grantee's center on health insurance reforms in providing policymakers and key stakeholders with educational resources and non-partisan technical assistance to support effective cost containment strategies.
$1.9M
American Journalism Project · Washington, DC · 2022
To support civic news organizations' business development.
$1.9M
American Journalism Project · Washington, DC · 2020
To support civic news organizations' business development.
$1.9M
Trustees of the University of Pennsylvania · Philadelphia, PA · 2024
To expand pwbm's ability to provide accurate, accessible, and transparent budget and economic analysis of public policy by providing more access to the model and data while deepening the model's capabilities.
$1.8M
Center for Health Policy Development · Portland, ME · 2020
To provide educational resources for prescription drug and commercial health care prices.
$1.8M
Memorial Sloan-Kettering Cancer Center · New York, NY · 2020
To support grantee's continued efforts to communicates viable, evidence-based methodologies and solutions to drug pricing that balance patient affordability with sustained incentives for innovation.
$1.7M
Research Triangle Institute · Research Triangle Park, NC · 2022
To conduct research on the public safety assessment in up to ten research and implementation sites.
$1.7M
Trustees of the University of Pennsylvania · Philadelphia, PA · 2022
To support implementation of the transitional care model across four hospital systems.
$1.7M
Social Finance · Boston, MA · 2022
To support the acceleration of donor-advised fund capital toward impact investing.
$1.6M
Oregon Health & Science University · Portland, OR · 2020
To fund the state medicaid alternative reimbursement and purchasing test for high cost drugs (smart-d) and support the development of value-based alternative drug purchasing models through pharmacy policy interventions,… read allTo fund the state medicaid alternative reimbursement and purchasing test for high cost drugs (smart-d) and support the development of value-based alternative drug purchasing models through pharmacy policy interventions, technical assistance, and education. less
$1.5M
Brown University · Providence, RI · 2020
To develop and fund initial operations of the brown policy lab.
$1.5M
Henry J Kaiser Family Foundation · San Francisco, CA · 2024
To support grantee's work in bringing greater attention and visibility to hospital and health system spending, prices, finance, and business practices that impact access to care and lead to higher costs for families, em… read allTo support grantee's work in bringing greater attention and visibility to hospital and health system spending, prices, finance, and business practices that impact access to care and lead to higher costs for families, employers, and the government. less
$1.5M
Massachusetts Institute of Technology · Cambridge, MA · 2024
To construct a cyclotron facility and procuring the installation of the first 30 mev proton beam within the cyclotron facility.
$1.5M
The Brigham and Women'S Hospital · Boston, MA · 2024
To support the program on regulation, therapeutics, and law ("portal") project on prescription drug policy and promoting meaningful drug innovation and regulation.
$1.5M
Mdrc · New York, NY · 2023
To advance evidence-based policy through high-quality research and technical assistance to generate sustainable, measurable change across several grantee divisions.
$1.5M
The Brigham and Womens Hospital · Boston, MA · 2023
To support the program on regulation, therapeutics, and law ("portal") project on prescription drug policy and promoting meaningful drug innovation and regulation.
$1.5M
Trustees of the University of Pennsylvania · Philadelphia, PA · 2023
To support improvement of the penn wharton budget model.
$1.5M
Massachusetts Institute of Technology · Cambridge, MA · 2022
For continued support of the state and local government innovation initiative.
$1.5M
Mdrc · New York, NY · 2022
To advance evidence-based policy through high-quality research and technical assistance to generate sustainable, measurable change across several grantee divisions.
$1.5M
Johns Hopkins University · Baltimore, MD · 2020
To develop and disseminate research on policy options that maximize access to and affordability of prescription drugs without stifling innovation.
$1.5M
Massachusetts Institute of Technology · Cambridge, MA · 2020
To support the state and local government innovation initiative at the abdul latif jameel poverty action lab's regional office in north america.
$1.5M
Regents University of California Los Angeles · Los Angeles, CA · 2020
To conduct a randomized controlled trial of the michigan contraceptive access research and evaluation program.
$1.5M
Per Scholas · Bronx, NY · 2020
To scale up grantee's workforce development program that provides information technology training for low-income adults.
$1.4M
Mdrc · New York, NY · 2020
To advance evidence-based policies that offer concrete, measurable, and lasting improvements to society.
$1.4M
Reason Foundation · Los Angeles, CA · 2020
To improve state and municipal pension systems.
$1.4M
Social Finance · Boston, MA · 2024
To support the acceleration of donor-advised fund capital toward impact investing.
$1.4M
Per Scholas · Bronx, NY · 2022
To scale up grantee's workforce development program that provides information technology training for low-income adults.
$1.3M
Mdrc · New York, NY · 2023
To study the impacts of preschool, summer curricula, and enhanced teacher training on early childhood learning.
$1.3M
The Council of State Governments · Lexington, KY · 2020
To implement a scalable technology solution to reduce revocations and recidivism in three states.
$1.3M
Mdrc · New York, NY · 2022
To advance evidence-based policies that offer concrete, measurable, and lasting improvements to society.
$1.3M
Colorado Seminary · Denver, CO · 2020
To help establish a policy lab in the state of colorado.
$1.3M
Rand Corporation · Santa Monica, CA · 2022
To conduct research on how to reduce gun violence.
$1.3M
Social Finance · Boston, MA · 2023
To support the acceleration of donor-advised fund capital toward impact investing.
$1.3M
Mathematica · Princeton, NJ · 2022
To support a randomized controlled trial to evaluate a nurse-led hospital discharge and home follow-up program for chronically ill older adults.
$1.3M
Committee for a Responsible Federal Budget · Washington, DC · 2024
To support fiscal policy work related to tax and budget policy.
$1.3M
Massachusetts Institute of Technology · Cambridge, MA · 2024
To support the state and local innovation initiative ("slii") of grantee's abdul latif jameel poverty action lab ("j-pal") north america.
$1.2M
Mdrc · New York, NY · 2020
To launch phase i of the scaling up community college efforts for student success (success) project to pilot and evaluate lower-cost student success interventions to improve such outcomes as completion and time-to-degre… read allTo launch phase i of the scaling up community college efforts for student success (success) project to pilot and evaluate lower-cost student success interventions to improve such outcomes as completion and time-to-degree. less
$1.2M
Mdrc · New York, NY · 2022
To study the impacts of preschool, summer curricula, and enhanced teacher training on early childhood learning.
$1.2M
Committee for a Responsible Federal Budget · Washington, DC · 2023
To support fiscal policy and higher education analysis work.
$1.2M
Committee for a Responsible Federal Budget · Washington, DC · 2022
To support fiscal policy and higher education analysis work.
$1.2M
University of Utah · Salt Lake City, UT · 2020
To provide technical support, capacity building resources, and training to reproductive health providers in utah.
$1.2M
University of Chicago · Chicago, IL · 2020
To pilot a project aimed at improving outcomes for youth ages 16 to 24 who are out of school and work in chicago.
$1.2M
Terner Housing Innovation Labs · Oakland, CA · 2024
To support (1) the scaling of grantee's housing supply simulator tool to new states and municipalities to assist policymakers and researchers in determining the market effects of individual land use policies and (2) pub… read allTo support (1) the scaling of grantee's housing supply simulator tool to new states and municipalities to assist policymakers and researchers in determining the market effects of individual land use policies and (2) publishing assessments on the most effective land use policies for increasing housing supply in various localities. less
$1.2M
Southern Poverty Law Center · Montgomery, AL · 2020
To support litigation and public education efforts concerning indigent incarceration and drivers license suspensions.
$1.1M
The Trustees of Princeton University · Princeton, NJ · 2023
To develop a research infrastructure that helps cities better understand and respond to waves of gun violence.
$1.1M
Center for Effective Public Policy · Kensington, MD · 2022
To provide technical assistance for pretrial reform implementation in illinois.
$1.1M
The City Fund · Falls Church, VA · 2020
To improve the quality of public education in cities across the united states.
$1.1M
Project On Predatory Student Lending · Jamaica Plain, MA · 2024
To provide general operating support.
$1.1M
University of Washington · Seattle, WA · 2022
To conduct research exploring the impacts of monetary sanctions and identifying alternative legal system reforms.
$1.1M
Rand Corporation · Santa Monica, CA · 2024
To support and expand grantee's gun policy in america initiative which provides the public, policymakers, and journalists with needed information on the effects of gun policies.
$1.1M
Mdrc · New York, NY · 2020
To evaluate the least burdensome release conditions and supervision practices that improve court appearance.
$1.1M
University of Southern California · Los Angeles, CA · 2020
To support further research and policy development on surprise medical billing, analysis on the relationship between private equity and commercial health care prices, and the development of affordability policies and st… read allTo support further research and policy development on surprise medical billing, analysis on the relationship between private equity and commercial health care prices, and the development of affordability policies and strategies to reduce health care prices. less
$1.1M
Regents University of California Los Angeles · Los Angeles, CA · 2020
To support the operations of the california policy lab, which seeks to improve california state and local government programs and policy.
$1.1M
Regents of the University of California at Berkeley · Berkeley, CA · 2020
To support the operations of the california policy lab, which seeks to improve california state and local government programs and policy.
$1.1M
Arizona State University Foundation for a New American University · Tempe, AZ · 2023
To develop domestic violence pretrial assessments.

View all 2,588 grants →

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990-PF, Part XV, as filed by the foundation. These are grants already paid — a record of what this funder backs, not an open call.